CClinicalTrials.gg
Status unknownNCT01285531Updated Feb 17, 2011

Pediatric Lumbar Puncture Success Using the COMPASS

An interventional study of Compass Lumbar Puncture Enhanced in Lumbar Puncture, sponsored by Seattle Children's Hospital. Status unknown at 1 site in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2011-02-17.

Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Feb 2011), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
Up to 18 Years
Sex
All
01

Study summary

Objective: To evaluate pediatric emergency department provider lumbar puncture success with and without the Compass Lumbar Puncture Enhanced, a new pressure transducer, in order to determine: the proportion of lumbar punctures where a) any cerebrospinal fluid is obtained on the first attempt, b) any cerebrospinal fluid is obtained on any attempt, and c) sufficient cerebrospinal fluid is obtained for standard tests (culture, chemistries, cell count); the time to provider success in obtaining a) a drop of fluid from the needle, and b) opening pressure measurement; the proportion of successful lumbar punctures that contain blood; and provider satisfaction.

Background: Lumbar punctures are necessary to diagnose meningitis, neurological diseases and some cancers. They are common pediatric emergency department procedures that frequently require repeated attempts or are only partially successful, with sufficient blood to limit interpretation. Measuring cerebrospinal fluid pressure during lumbar punctures is recommended but rarely done, due to limitations of current technology. Liquid column manometry is cumbersome, time-consuming and frequently impractical. Existing pressure transduction probes that connect via tubing to external monitors are not designed or recommended for lumbar punctures. The pressure is displayed on a monitor that is difficult to view during the LP procedure and they equilibrate too slowly to keep pace of pressure changes during LPs. The Compass Lumbar Puncture Enhanced is a new, inexpensive, disposable, medical device, specifically designed for use during LPs, that has the potential to increase lumbar punctures success and decrease blood contamination. It attaches to the spinal needle and displays both a numeric pressure value and a pressure waveform, allowing physicians to more readily identify the cerebrospinal fluid space and measure cerebrospinal fluid pressure. The device is small, easy to use, and readily incorporated into standard practice.

The Compass Lumbar Puncture Enhanced uniquely provides immediate feedback about pressure that may allow physicians to more quickly and confidently identify the CSF space, and instantly determine cerebrospinal fluid pressure when the space is reached. The investigators believe the Compass Lumbar Puncture Enhanced will increase lumbar punctures success and decrease the proportion containing blood. It has the potential to become the standard of care and be used in every lumbar puncture procedure. This study is expected to demonstrate the clinical utility of the Compass Lumbar Puncture Enhanced to the medical community. Increased awareness of the Compass Lumbar Puncture Enhanced and a positive demonstration of the viability of the technology will help attract either the investment capital or the strategic partnership necessary to fully develop the market.

Read the detailed description

Objective: To evaluate pediatric emergency department (ED) provider lumbar puncture success with and without the Compass Lumbar Puncture Enhanced, a new pressure transducer, in order to determine: the proportion of lumbar punctures (LPs) where a) any cerebrospinal fluid (CSF) is obtained on the first attempt, b) any CSF is obtained on any attempt, and c) sufficient CSF is obtained for standard tests (culture, chemistries, cell count); the time to provider success in obtaining a) a drop of fluid from the needle, and b) opening pressure measurement; the proportion of successful lumbar punctures that contain blood; and provider satisfaction.

Background: Lumbar punctures are necessary to diagnose meningitis, neurological diseases and some cancers. They are common pediatric emergency department procedures that frequently require repeated attempts or are only partially successful, with sufficient blood to limit interpretation. Measuring cerebrospinal fluid pressure during a lumbar puncture is recommended but rarely done, due to limitations of current technology. Liquid column manometry is cumbersome, time-consuming and frequently impractical. Existing pressure transduction probes that connect via tubing to external monitors are not designed or recommended for LPs. The pressure is displayed on a monitor that is difficult to view during the lumbar puncture procedure and they equilibrate too slowly to keep pace of pressure changes during lumbar puncture. The Compass Lumbar Puncture Enhanced is a new, inexpensive, disposable, medical device, specifically designed for use during lumbar punctures, that has the potential to increase lumbar puncture success and decrease blood contamination. It attaches to the spinal needle and displays both a numeric pressure value and a pressure waveform, allowing physicians to more readily identify the cerebrospinal fluid space and measure cerebrospinal fluid pressure. The device is small, easy to use, and readily incorporated into standard practice.

Methods: This randomized clinical trial will test adding the Compass Lumbar Puncture Enhanced vs. standard care in 60 children 0-16 years old who are receiving a lumbar puncture in the Seattle Children's Hospital Emergency Department. We will test the Compass Lumbar Puncture Enhanced against standard care in 60 children receiving lumbar puncture, comparing success, pressures obtaining, time to success, complications (e.g. >200 red blood cells/mm3) and provider satisfaction. Results will be compared with chi-squared tests, regressions, Kaplan-Meier and logrank tests. We expect improved success, decreased time to success and complications and high provider satisfaction.

Impact: Currently, one third of lumbar punctures require multiple attempts, 7-20% contain blood that limits interpretation, and 6% are unsuccessful. This results in unnecessary hospitalizations, increased hospital days, increased antibiotic use and increased numbers of repeat procedures. The Compass Lumbar Puncture Enhanced uniquely provides immediate feedback about pressure that will allow physicians to more quickly and confidently identify the cerebrospinal fluid space, and instantly determine cerebrospinal fluid pressure when the space is reached. We believe the Compass Lumbar Puncture Enhanced will increase lumbar puncture success and decrease the proportion containing blood. It has the potential to become the standard of care and be used in every lumbar puncture procedure. This study is expected to demonstrate the clinical utility of the Compass Lumbar Puncture Enhanced to the medical community.

02

Conditions studied

  • Lumbar Puncture

Browse trials for

Keywords

  • lumbar puncture
  • Compass
  • pressure transducer
  • manometry
  • The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Seattle Children's Hospital is the lead sponsor of 210 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 0 - 18 years old
  • Patient was in the Seattle Children's Hospital (SCH) Emergency Department (ED)within 24 hours
  • Patient requires lumbar puncture (can be performed in the ED or inpatient, within 24 hours of arrival to the ED)
  • Parent is able to read English or Spanish
  • A provider who is trained in the use of the Compass device is willing and able to use it during the LP

Exclusion criteria

Exclusion Criteria:

  • Child is a foster child or ward of the state or is unaccompanied by their legal guardian
  • Child has a lower spine deformity, such as spina bifida, that would impact lP success
  • The child is pregnant, by verbal report or clinically available test results
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Lumbar puncture

    The participants randomly assigned to this arm will receive a lumbar puncture using standard procedures and equipment

  • Experimental
    Lumbar puncture with the Compass device

    The participants randomly assigned to this group will receive a lumbar puncture with the use of the Compass device.

    Device: Compass Lumbar Puncture Enhanced

Interventions

  • DeviceCompass Lumbar Puncture Enhanced

    Participants randomly assigned to this group will receive a lumbar puncture using the Compass device.

    Also known as: compass

06

What researchers measure

Primary outcomes

  1. Lumbar puncture success

    Time to lumbar puncture success. In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the proportion of LPs where any CSF is obtained on any attempt

    Time frame: 1 minute to 2 hours

Secondary outcomes

  1. Obtaining CSF fluid

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the proportion of LPs where any CSF is obtained on any attempt

    Time frame: 1 minute to 2 hours

  2. Obtain sufficient CSF fluid

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the proportion of LPs where sufficient CSF is obtained for standard tests (culture, chemistries and cell count) on any attempt

    Time frame: 1 minute to 2 hours

  3. Successful traumatic LPs (contaminated with blood)

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the proportion of successful LPs that are traumatic (contaminated with blood)

    Time frame: 1 minute to 2 hours

  4. Time to fluid

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the time to provider success in obtaining a drop of fluid from the needle

    Time frame: 1 minute to 2 hours

  5. Time to LP opening pressure

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine the time to provider success in obtaining opening pressure measurement

    Time frame: 1 minute to 2 hours

  6. Provider satisfaction

    In pediatric patients receiving emergency department care, we aim to evaluate pediatric ED provider LP success with and without the Compass, in order to determine provider satisfaction with the procedure +/- device.

    Time frame: 1 minute to 2 hours

07

Study locations

1 of 1 sites recruiting
  • Seattle Children's Hospital
    Seattle, Washington 98105, United States
    • Julie C. Brown, MD, MPH · Contact · julie.brown@seattlechildrens.org · 206-987-4016
    • Daniel P. Osincup, BA · Contact · daniel.osincup@seattlechildrens.org · 206-987-2939
    • Julie C Brown, MD, MPH · Principal investigator
    • Eileen J Klein, MD, MPH · Sub investigator
    • Jennifer Reid, MD · Sub investigator
    • Ana Kobayashi, MPH · Sub investigator
    • Daniel Osincup, BA · Sub investigator
    • Bonnie Strelitz, MPH · Sub investigator
    • Carrie Pettler, BA · Sub investigator
    • Anne Birkel, BA · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01285531
Lead sponsor
Seattle Children's Hospital
Collaborators
Life Sciences Development Fund
First posted
Jan 28, 2011
Start date
Jan 2011
Primary completion
Jan 2012 (estimated)
Last update
Feb 17, 2011

Study contacts

Julie C Brown, MD, MPH
Contact
julie.brown@seattlechildrens.org
206-987-4016
Daniel P. Osincup, BA
Contact
daniel.osincup@seattlechildrens.org
206-987-2939
JUlie C. Brown, MD, MPH
principal investigator · Seattle Children's Hospital, Pediatric Emergency Department

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion